Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 2.2 to 1.8.
Financials
Financial year 2025
OPHTALMEO from Gembloux, company number BE0470623412, closed financial year 2025 with a result of € 409,020 after tax. For that financial year OPHTALMEO recorded a gross margin of € 737,559 and equity of € 4.4 million. Compared with financial year 2024, the result moved from € 431,721 to € 409,020. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 4.4 million
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 409,020
▼ 5% vs 2024
Profit after tax over the fiscal year.
€ 478,752
▼ 56% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 4.3 million.
People and assets in 2025
1.8
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 92,359
▼ 7% vs 2024
€ 51,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 42,866
▼ 30% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 799
▼ 50% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 73,077
▼ 35% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 510,956 | € 626,289 | € 760,161 | € 737,559 | ▼ 3% |
| Profit after taxes | € 206,282 | € 331,145 | € 431,721 | € 409,020 | ▼ 5% |
| Equity | € 3,180,858 | € 3,512,003 | € 3,943,724 | € 4,352,744 | ▲ 10% |
| Total debts | € 65,276 | € 124,045 | € 135,786 | € 89,233 | ▼ 34% |
| Cash | € 1,797,152 | € 648,255 | € 1,076,709 | € 478,752 | ▼ 56% |
| Land & buildings | € 291,542 | € 268,439 | € 225,662 | € 193,426 | ▼ 14% |
| Retained profit | € 3,174,658 | € 3,505,803 | € 3,937,524 | € 4,346,544 | ▲ 10% |
| Balance sheet total | € 3,246,134 | € 3,636,048 | € 4,079,510 | € 4,441,977 | ▲ 9% |
| Employees (FTE) | 2.2 | 2.2 | 1.9 | 1.8 | ▼ 0.1 |
Key figures of OPHTALMEO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to OPHTALMEO?
What happened at OPHTALMEO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 409,020 (▼ 5% vs 2024). filed late Source: NBB ↗
- Jean-Paul HARDY became a director. NBB
- Bénédicte JANSSENS became a director. NBB
- New establishment in Gembloux. KBO
- Start of the company according to the CBE. KBO
In short
From € 206,282 profit in 2022 to € 409,020 profit in 2025.
Paid € 653,043 in corporate taxes since 2022.
Best year ever: 2024, with € 431,721 profit.
On average € 409,800 of value added per employee in 2025.
Management
Behind OPHTALMEO are Jean-Paul HARDY and Bénédicte JANSSENS.
Directors
According to the 2025 annual accounts
Jean-Paul HARDY
Director
since 2023
Bénédicte JANSSENS
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Rue Buisson-Saint-Guibert 52
5030 Gembloux
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0470.623.412
- VAT number
- BE 0470.623.412
- Registered office
- Rue Buisson-Saint-Guibert 52, 5030 Gembloux
- Names & denominations
- OPHTALMEO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 February 2000
- Peppol
- Active · Active since 8 Nov 2025
- Activities · NACE
Activiteiten van medisch specialisten
Medische praktijken